We are live on
!
Find out more
Parnassus Investments Portfolio holdings
AUM
$37.4B
1-Year Est. Return
35.42%
This Fund
S&P 500
This Quarter
Est. Return
+12.51%
1 Year Est. Return
+35.42%
3 Year Est. Return
+106.24%
5 Year Est. Return
+128.96%
10 Year Est. Return
+492.3%
AUM
$43.4B
AUM Growth
+$1.74B
(+4.2%)
Cap. Flow
-$2.16B
Cap. Flow
% of AUM
-4.99%
Top 10 Holdings %
Top 10 Hldgs %
38.55%
Holding
157
New
22
Increased
31
Reduced
95
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$483M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$311M |
| 3 |
Willis Towers Watson
WTW
|
+$106M |
| 4 |
Alcon
ALC
|
+$82.2M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$56.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$838M |
| 2 |
Microsoft
MSFT
|
+$524M |
| 3 |
Ball Corp
BALL
|
+$195M |
| 4 |
Pfizer
PFE
|
+$112M |
| 5 |
Simon Property Group
SPG
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.06% |
| 2 | Financials | 16.65% |
| 3 | Industrials | 12.24% |
| 4 | Healthcare | 11.49% |
| 5 | Consumer Discretionary | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Progressive
PGR
$129B
| $105M | 0.24% |
392,685
-18,904
| -5% | -$5.18M |
|
|
52
Willis Towers Watson
WTW
$31.9B
| $105M | 0.24% |
+341,414
| New | +$106M |
|
53
TSMC
TSM
$2.17T
| $104M | 0.24% |
457,244
-30,130
| -6% | -$5.58M |
|
54
Fidelity National Information Services
FIS
$21B
| $101M | 0.23% |
1,234,774
-79,853
| -6% | -$6.21M |
|
55
Autodesk
ADSK
$53.8B
| $97.4M | 0.22% |
314,702
-18,797
| -6% | -$5.33M |
|
56
Broadridge
BR
$20.7B
| $95.5M | 0.22% |
392,798
-45,683
| -10% | -$10.9M |
|
57
JB Hunt Transport Services
JBHT
$24.8B
| $95.2M | 0.22% |
663,090
-85,183
| -11% | -$11.8M |
|
|
58
Cigna
CI
$74.2B
| $94.5M | 0.22% |
285,917
-2,599,666
| -90% | -$838M |
|
59
Visa
V
$717B
| $94.5M | 0.22% |
266,080
-4,897
| -2% | -$1.71M |
|
60
Airbnb
ABNB
$111B
| $92.6M | 0.21% |
699,766
-7,009
| -1% | -$888K |
|
61
Western Digital
WDC
$169B
| $92M | 0.21% |
1,437,621
-1,115,993
| -44% | -$53.1M |
|
62
AstraZeneca
AZN
$258B
| $89.9M | 0.21% |
643,490
+31,110
| +5% | +$4.36M |
|
63
TransUnion
TRU
$16.2B
| $88.5M | 0.2% |
1,006,054
-69,616
| -6% | -$5.81M |
|
64
FedEx
FDX
$79.5B
| $87.3M | 0.2% |
384,194
+14,826
| +4% | +$3.25M |
|
65
Citigroup
C
$224B
| $86.9M | 0.2% |
1,021,369
-231,067
| -18% | -$16.7M |
|
66
Republic Services
RSG
$68B
| $86.9M | 0.2% |
352,433
-51,128
| -13% | -$12.6M |
|
67
CME Group
CME
$101B
| $86.6M | 0.2% |
314,138
-1,841
| -0.6% | -$501K |
|
68
Cboe Global Markets
CBOE
$32.6B
| $83M | 0.19% |
356,111
-52,094
| -13% | -$11.6M |
|
69
Hilton Worldwide
HLT
$74.8B
| $82.9M | 0.19% |
311,242
+64,838
| +26% | +$15.4M |
|
|
70
Alcon
ALC
$35.1B
| $80.9M | 0.19% |
+916,801
| New | +$82.2M |
|
71
Agilent Technologies
A
$43.8B
| $79.5M | 0.18% |
674,048
-903,951
| -57% | -$100M |
|
72
Nice
NICE
$5.92B
| $78.8M | 0.18% |
466,429
-84,033
| -15% | -$13.5M |
|
73
Bio-Rad Laboratories Class A
BIO
$10.4B
| $76.6M | 0.18% |
317,218
-893
| -0.3% | -$211K |
|
74
Ares Management
ARES
$32B
| $73.1M | 0.17% |
422,328
+337,989
| +401% | +$53.4M |
|
75
Comcast
CMCSA
$96.5B
| $71M | 0.16% |
1,989,492
+63,967
| +3% | +$2.21M |
|
Similar funds
ECSS
PIF
TWC
Parnassus Investments's Q2 2025 Portfolio in Review
As of Q2 2025, Parnassus Investments held 157 positions worth $43.4B, up 4.2% from $41.6B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parnassus Investments withdrew a net $2.16B in Q2 2025, closing 9 positions and reducing 95 holdings. Its most notable exit was Pfizer, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
Against the trend, Parnassus Investments opened a new position in Willis Towers Watson worth $105M.
- Parnassus Investments's largest Q2 2025 buy was Willis Towers Watson: 341,414 shares worth $105M.
- Parnassus Investments added most to Danaher in Q2 2025, an estimated $483M increase.
- Parnassus Investments's biggest Q2 2025 reduction was Cigna, cutting an estimated $838M.
- Parnassus Investments fully exited Pfizer in Q2 2025, selling an estimated $112M.
- Parnassus Investments's ten largest holdings make up 39% of its $43.4B portfolio in Q2 2025.
- Parnassus Investments opened 22 new positions and closed 9 in Q2 2025.
- Parnassus Investments's portfolio value rose 4.2% quarter-over-quarter to $43.4B.
Based on Parnassus Investments's 13F filing for Q2 2025, filed 6 Aug 2025.